GlassScriptPhysician profile
Alison J Ball
NPI 1427345263
$3,390.17
in general payments reported to CMS, 2019-2025
41 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $288 · 2021: $40.49 · 2022: $259 · 2023: $410 · 2024: $571 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,143.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $676.43 | 2021-2025 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $386.95 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $372.13 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Pfizer INC. | $288.12 | 2019-2025 | |
| Amgen INC. | $217.47 | 2019-2025 | Repatha, Otezla, Repatha |
| Aimmune Therapeutics, INC. | $117.29 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.58 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $74.46 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $73.53 | 2019-2023 | Flumist Quadrivalent |
| Regeneron Healthcare Solutions, INC. | $71.46 | 2019-2020 | |
| Exact Sciences Corporation | $69.43 | 2023-2025 | Cologuard Collection Kit |
| Procept Biorobotics Corporation | $67.56 | 2024 | Aquabeam System |
| Abbott Laboratories | $64.79 | 2022-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $61.07 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $56.82 | 2024-2025 | Rexulti |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.